Literature DB >> 9360935

Salai Guggal - Boswellia serrata: from a herbal medicine to a non-redox inhibitor of leukotriene biosynthesis.

H P Ammon.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9360935

Source DB:  PubMed          Journal:  Eur J Med Res        ISSN: 0949-2321            Impact factor:   2.175


× No keyword cloud information.
  9 in total

1.  Effect of Boswellia serrata on intestinal motility in rodents: inhibition of diarrhoea without constipation.

Authors:  Francesca Borrelli; Francesco Capasso; Raffaele Capasso; Valeria Ascione; Gabriella Aviello; Rocco Longo; Angelo A Izzo
Journal:  Br J Pharmacol       Date:  2006-04-24       Impact factor: 8.739

2.  Identification of novel anti-inflammatory agents from Ayurvedic medicine for prevention of chronic diseases: "reverse pharmacology" and "bedside to bench" approach.

Authors:  Bharat B Aggarwal; Sahdeo Prasad; Simone Reuter; Ramaswamy Kannappan; Vivek R Yadev; Byoungduck Park; Ji Hye Kim; Subash C Gupta; Kanokkarn Phromnoi; Chitra Sundaram; Seema Prasad; Madan M Chaturvedi; Bokyung Sung
Journal:  Curr Drug Targets       Date:  2011-10       Impact factor: 3.465

3.  Boswellic acid inhibits growth and metastasis of human colorectal cancer in orthotopic mouse model by downregulating inflammatory, proliferative, invasive and angiogenic biomarkers.

Authors:  Vivek R Yadav; Sahdeo Prasad; Bokyung Sung; Juri G Gelovani; Sushovan Guha; Sunil Krishnan; Bharat B Aggarwal
Journal:  Int J Cancer       Date:  2011-09-12       Impact factor: 7.396

Review 4.  Boswellia serrata: an overall assessment of in vitro, preclinical, pharmacokinetic and clinical data.

Authors:  Mona Abdel-Tawab; Oliver Werz; Manfred Schubert-Zsilavecz
Journal:  Clin Pharmacokinet       Date:  2011-06       Impact factor: 6.447

5.  Boswellia carterii extract inhibits TH1 cytokines and promotes TH2 cytokines in vitro.

Authors:  Marc R Chevrier; Abigail E Ryan; David Y-W Lee; Ma Zhongze; Zhang Wu-Yan; Charles S Via
Journal:  Clin Diagn Lab Immunol       Date:  2005-05

6.  The selective 5-LOX inhibitor 11-keto-β-boswellic acid protects against myocardial ischemia reperfusion injury in rats: involvement of redox and inflammatory cascades.

Authors:  Shimaa M Elshazly; Dalia M Abd El Motteleb; Noha N Nassar
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-06-15       Impact factor: 3.000

7.  Boswellic acid suppresses growth and metastasis of human pancreatic tumors in an orthotopic nude mouse model through modulation of multiple targets.

Authors:  Byoungduck Park; Sahdeo Prasad; Vivek Yadav; Bokyung Sung; Bharat B Aggarwal
Journal:  PLoS One       Date:  2011-10-31       Impact factor: 3.752

8.  Boswellic acids and malignant glioma: induction of apoptosis but no modulation of drug sensitivity.

Authors:  T Glaser; S Winter; P Groscurth; H Safayhi; E R Sailer; H P Ammon; M Schabet; M Weller
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

9.  Combined acetyl-11-keto-β-boswellic acid and radiation treatment inhibited glioblastoma tumor cells.

Authors:  Sefora Conti; Akiva Vexler; Liat Edry-Botzer; Lital Kalich-Philosoph; Benjamin W Corn; Natan Shtraus; Yaron Meir; Lior Hagoel; Alexander Shtabsky; Sylvia Marmor; Gideon Earon; Shahar Lev-Ari
Journal:  PLoS One       Date:  2018-07-03       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.